益生元改善胃旁路术后绝经后女性钙吸收:一项随机对照试验
这项随机双盲安慰剂对照试验纳入20例平均5年前接受Roux-en-Y胃旁路术(RYGB)的绝经后女性,口服可溶性玉米纤维(SCF)20 g/日或麦芽糊精安慰剂2个月。主要结局为钙吸收分数(FCA)绝对变化,结果显示组间无差异(+3.4 [-6.7, +13.6]%),SCF耐受性良好,但置信区间宽提示SCF影响存在变异,可能与肠道微生物改变程度有关。
要点
- RYGB术后绝经后女性基线FCA低,为5.5 ± 5.1%。
- SCF组与安慰剂组FCA变化无组间差异,95%CI宽(+3.4 [-6.7, +13.6]%)。
- SCF组FCA变化变异大于安慰剂组(SD 13.4% vs 7.0%),微生物组成改变较大者FCA增加较多(r2=0.72,P=0.05)。
核心结论
- SCF与安慰剂相比,FCA变化及钙调节激素、骨转换标志物均无组间差异,但宽置信区间提示SCF影响存在变异,可能与肠道微生物改变程度有关。
- 每日SCF摄入耐受性良好,需更大规模和更长期的研究。
研究设计与样本
- 随机、双盲、安慰剂对照试验,纳入20例有RYGB史的绝经后女性,平均距手术5年。
- 干预为口服SCF 20 g/日或麦芽糊精安慰剂2个月。
- 主要结局为FCA绝对变化的组间差异,采用金标准双稳定同位素法测定。
主要发现
- 基线平均FCA ± SD为5.5 ± 5.1%。
- SCF组与安慰剂组FCA平均变化(95%CI)为+3.4 [-6.7, +13.6]%,无组间差异。
- 钙调节激素和骨转换标志物无组间差异。
- SCF组FCA变化的SD为13.4%,安慰剂组为7.0%。
- 微生物组成改变较大者FCA增加较多(r2 = 0.72,P = 0.05)。
临床怎么用
- 原文未据此给出临床推荐。
局限性
- 置信区间宽。
- 需更大规模和更长期的研究。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
CONTEXT: The adverse skeletal effects of Roux-en-Y gastric bypass (RYGB) are partly caused by intestinal calcium absorption decline. Prebiotics, such as soluble corn fiber (SCF), augment colonic calcium absorption in healthy individuals. OBJECTIVE: We tested the effects of SCF on fractional calcium absorption (FCA), biochemical parameters, and the fecal microbiome in a post-RYGB population. METHODS: Randomized, double-blind, placebo-controlled trial of 20 postmenopausal women with history of RYGB a mean 5 years prior; a 2-month course of 20 g/day SCF or maltodextrin placebo was taken orally. The main outcome measure was between-group difference in absolute change in FCA (primary outcome) and was measured with a gold standard dual stable isotope method. Other measures included tolerability, adherence, serum calciotropic hormones and bone turnover markers, and fecal microbial composition via 16S rRNA gene sequencing. RESULTS: Mean FCA ± SD at baseline was low at 5.5 ± 5.1%. Comparing SCF to placebo, there was no between-group difference in mean (95% CI) change in FCA (+3.4 [-6.7, +13.6]%), nor in calciotropic hormones or bone turnover markers. The SCF group had a wider variation in FCA change than placebo (SD 13.4% vs 7.0%). Those with greater change in microbial composition following SCF treatment had greater increase in FCA (r2 = 0.72, P = 0.05). SCF adherence was high, and gastrointestinal symptoms were similar between groups. CONCLUSION: No between-group differences were observed in changes in FCA or calciotropic hormones, but wide CIs suggest a variable impact of SCF that may be due to the degree of gut microbiome alteration. Daily SCF consumption was well tolerated. Larger and longer-term studies are warranted.
引用
- Wu KC, Cao S, Weaver CM, et al. Prebiotic to Improve Calcium Absorption in Postmenopausal Women After Gastric Bypass: A Randomized Controlled Trial. J Clin Endocrinol Metab. 2022. PMID: 34888663. doi:10.1210/clinem/dgab883
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。